Preview

Malignant tumours

Advanced search

Commentary on the publication of Yargunin S.A. et al. “Dynamics of changes in tumor-associated macrophages in patients with primary skin melanoma depending on the method of surgical treatment”

https://doi.org/10.18027/2224-5057-2023-13-3-5-7

About the Authors

Н. Н. Петенко
ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России
Russian Federation


А. О. Кузьменко
ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России
Russian Federation


И. В. Самойленко
ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России
Russian Federation


References

1. MacCormack MA, Cohen LM, Rogers GS : Local melanoma recurrence : a clarification of terminology. Dermatol Surg 2004, 30 (12 Pt 2) : 1533–1538.

2. Heenan PJ, Ghaznawie M : The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg 1999, 52 (3) : 209–213.

3. Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS : The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 1984, 200 (6) : 759–763.

4. Bittar PG, Bittar JM, Etzkorn JR, Brewer JD, Aizman L, Shin TM, Sobanko JF, Higgins HW, Giordano CN, Cohen JV et al : Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision. J Am Acad Dermatol 2021, 85 (3) : 681–692.

5. Барышников КА : Иссечение послеоперационных рубцов при меланоме кожи: можем ли мы отказаться от традиций?. In : Ежегодная конференция Ассоциации специалистов по проблемам меланомы «МЕЛАНОМА И ОПУХОЛИ КОЖИ 2023» 2013 ; Москва : НО «Ассоциации специалистов по проблемам меланомы»; 2013.

6. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM et al : Prognostic factors analysis of 17,600 melanoma patients : validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19 (16) : 3622–3634.

7. Ascierto PA, Khattak MA, Merino LdlC, Vecchio MD, Rutkowski P, Spagnolo F, Mackiewicz J, Chiarion-Sileni V, Kirkwood JMM, Robert C et al : Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma : Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study. Journal of Clinical Oncology 2023, 41 (17_suppl) : LBA9505-LBA9505.

8. Ackerman AB : Mythology and numerology in the sphere of melanoma. Cancer 2000, 88 (3) : 491–496.

9. Gastman BR, Gerami P, Kurley SJ, Cook RW, Leachman S, Vetto JT : Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol 2019, 80 (1) : 149–157 e144.


Review

For citations:


Петенко Н.Н., Кузьменко А.О., Самойленко И.В. Commentary on the publication of Yargunin S.A. et al. “Dynamics of changes in tumor-associated macrophages in patients with primary skin melanoma depending on the method of surgical treatment”. Malignant tumours. 2023;13(3):5-7. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-3-5-7

Views: 248


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)